Congenica
2012
FOUNDED
PRIVATE
STATUS
71-80
EMPLOYEES
Series B
LATEST DEAL TYPE
$30.3M
LATEST DEAL AMOUNT
10
INVESTORS
Description
Developer of a clinical genome interpretation software designed to identify genetic diseases in patients. The company's clinical genomic analytics platform processes genomic datasets to detect mutations by filtering clinically relevant variants and deep clinical phenotyping, enabling clinicians and researchers to interrogate the human genome to identify disease-causing variants.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Primary Office
- Wellcome Genome Campus
- Cambridge CB10 1DR
- England, United Kingdom
+44 01223 000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Congenica’s full profile, request a free trial.
Congenica Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B) | 30-Apr-2019 | $30.3M | 000.00 | 0000 | Completed | Generating Revenue |
| 6. Grant | 29-Sep-2015 | 00000 | 00.000 | Completed | Generating Revenue | |
| 5. Early Stage VC (Series A) | 01-Apr-2015 | 00.000 | 00.000 | 00.00 | Completed | Generating Revenue |
| 4. Grant | 11-Mar-2015 | 00.000 | 00.000 | Completed | Startup | |
| 3. Seed Round | 05-Dec-2014 | 00.000 | 00.000 | Completed | Startup | |
| 2. Seed Round | 01-Oct-2014 | $814K | $814K | 00.000 | Completed | Startup |
| 1. Grant | 02-May-2014 | $570K | Completed | Startup |
Congenica Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| A Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| A Ordinary | 2,553,500 | $0.001493 | $0.29 | $0.29 | 1x | $0.29 | 20.88% | |
| Ordinary | 500,000 | $0.001493 | $0.01 | $0.01 | 1x | $0.01 | 4.09% |
Congenica Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genalice | Formerly PE-Backed | Harderwijk, Netherlands | 00 | 000000 - 000 | ||
| 000000 00000000 | Formerly VC-backed | Hercules, CA | 00 | 00.000 | 000000&0 | 00.000 |
| 000000 (0000 00000 | Venture Capital-Backed | Bangalore, India | 000 | 000.00 | 0000000000 0 | 000.00 |
| 000000 00000000 | Venture Capital-Backed | Oakland, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Venture Capital-Backed | Ann Arbor, MI | 0 | 00.000 | 000000000 | 00.000 |
Congenica Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| BGI | PE-Backed Company | Minority | 000 0000 | 000000 0 | ||
| Digital China Health | Corporation | Minority | 000 0000 | 000000 0 | ||
| Future Planet Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| Healthlink Capital | Other | Minority | 000 0000 | 000000 0 | ||
| Parkwalk Advisors | Venture Capital | Minority | 000 0000 | 000000 0 |
Congenica Executive Team (16)
7 Former Executives
You’re viewing 5 of 16 executives. Get the full list »Congenica Board Members (15)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alastair Kilgour | Parkwalk Advisors | Board Member | 000 0000 | |
| Andrew Richards | Congenica | Chairman | 000 0000 | |
| David Atkins Ph.D | Congenica | Chief Executive Officer & Board Member | 000 0000 | |
| Matthew Hurles Ph.D | Congenica | Co-Founder, Scientific Director & Board Member | 000 0000 | |
| Michael Anstey Ph.D | Cambridge Innovation Capital | Board Member | 000 0000 |
8 Former Board Members
You’re viewing 5 of 15 board members. Get the full list »